Biosig issues letter to shareholders detailing technology innovations and strategic focus for 2024

Westport, ct, dec. 06, 2023 (globe newswire) -- biosig technologies, inc. (nasdaq: bsgm) (“biosig” or the “company”), a medical technology company delivering unprecedented accuracy and precision to intracardiac signal visualization, today issued its 2023 letter to shareholders to recap recent achievements and offer insights about the year ahead.

BSGM Ratings Summary

BSGM Quant Ranking